Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 218

1.

Protocadherin 10 suppresses tumorigenesis and metastasis in colorectal cancer and its genetic loss predicts adverse prognosis.

Jao TM, Tsai MH, Lio HY, Weng WT, Chen CC, Tzeng ST, Chang CY, Lai YC, Yen SJ, Yu SL, Yang YC.

Int J Cancer. 2014 Dec 1;135(11):2593-603. doi: 10.1002/ijc.28899. Epub 2014 Apr 23.

2.

Mapping of genetic deletions on chromosome 3 in colorectal cancer: loss of 3p25-pter is associated with distant metastasis and poor survival.

Tsai MH, Fang WH, Lin SH, Tzeng ST, Huang CS, Yen SJ, Chou SJ, Yang YC.

Ann Surg Oncol. 2011 Sep;18(9):2662-70. doi: 10.1245/s10434-011-1603-9. Epub 2011 Feb 23.

PMID:
21347784
3.

NDST4 is a novel candidate tumor suppressor gene at chromosome 4q26 and its genetic loss predicts adverse prognosis in colorectal cancer.

Tzeng ST, Tsai MH, Chen CL, Lee JX, Jao TM, Yu SL, Yen SJ, Yang YC.

PLoS One. 2013 Jun 25;8(6):e67040. doi: 10.1371/journal.pone.0067040. Print 2013.

4.

Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer.

Yu J, Cheng YY, Tao Q, Cheung KF, Lam CN, Geng H, Tian LW, Wong YP, Tong JH, Ying JM, Jin H, To KF, Chan FK, Sung JJ.

Gastroenterology. 2009 Feb;136(2):640-51.e1. doi: 10.1053/j.gastro.2008.10.050. Epub 2008 Oct 29.

PMID:
19084528
5.

Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis.

Yokobori T, Iinuma H, Shimamura T, Imoto S, Sugimachi K, Ishii H, Iwatsuki M, Ota D, Ohkuma M, Iwaya T, Nishida N, Kogo R, Sudo T, Tanaka F, Shibata K, Toh H, Sato T, Barnard GF, Fukagawa T, Yamamoto S, Nakanishi H, Sasaki S, Miyano S, Watanabe T, Kuwano H, Mimori K, Pantel K, Mori M.

Cancer Res. 2013 Apr 1;73(7):2059-69. doi: 10.1158/0008-5472.CAN-12-0326. Epub 2013 Feb 1.

6.

Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer.

Toiyama Y, Yasuda H, Saigusa S, Tanaka K, Inoue Y, Goel A, Kusunoki M.

Carcinogenesis. 2013 Nov;34(11):2548-57. doi: 10.1093/carcin/bgt282. Epub 2013 Sep 3.

7.

OCT4 regulates epithelial-mesenchymal transition and its knockdown inhibits colorectal cancer cell migration and invasion.

Dai X, Ge J, Wang X, Qian X, Zhang C, Li X.

Oncol Rep. 2013 Jan;29(1):155-60. doi: 10.3892/or.2012.2086. Epub 2012 Oct 17.

PMID:
23076549
8.

GATA6 predicts prognosis and hepatic metastasis of colorectal cancer.

Shen F, Li J, Cai W, Zhu G, Gu W, Jia L, Xu B.

Oncol Rep. 2013 Sep;30(3):1355-61. doi: 10.3892/or.2013.2544. Epub 2013 Jun 19.

PMID:
23784465
9.

MicroRNA-181a promotes tumor growth and liver metastasis in colorectal cancer by targeting the tumor suppressor WIF-1.

Ji D, Chen Z, Li M, Zhan T, Yao Y, Zhang Z, Xi J, Yan L, Gu J.

Mol Cancer. 2014 Apr 23;13:86. doi: 10.1186/1476-4598-13-86.

10.

Overexpression of YAP and TAZ is an independent predictor of prognosis in colorectal cancer and related to the proliferation and metastasis of colon cancer cells.

Wang L, Shi S, Guo Z, Zhang X, Han S, Yang A, Wen W, Zhu Q.

PLoS One. 2013 Jun 10;8(6):e65539. doi: 10.1371/journal.pone.0065539. Print 2013.

11.

High levels of SIRT1 expression enhance tumorigenesis and associate with a poor prognosis of colorectal carcinoma patients.

Chen X, Sun K, Jiao S, Cai N, Zhao X, Zou H, Xie Y, Wang Z, Zhong M, Wei L.

Sci Rep. 2014 Dec 15;4:7481. doi: 10.1038/srep07481.

12.

UHRF1 promotes cell growth and metastasis through repression of p16(ink⁴a) in colorectal cancer.

Wang F, Yang YZ, Shi CZ, Zhang P, Moyer MP, Zhang HZ, Zou Y, Qin HL.

Ann Surg Oncol. 2012 Aug;19(8):2753-62. doi: 10.1245/s10434-011-2194-1. Epub 2012 Jan 5.

PMID:
22219067
13.

Aberrant expression of plastin-3 via copy number gain induces the epithelial-mesenchymal transition in circulating colorectal cancer cells.

Sugimachi K, Yokobori T, Iinuma H, Ueda M, Ueo H, Shinden Y, Eguchi H, Sudo T, Suzuki A, Maehara Y, Mori M, Mimori K.

Ann Surg Oncol. 2014 Oct;21(11):3680-90. doi: 10.1245/s10434-013-3366-y. Epub 2013 Nov 12.

PMID:
24217791
14.

Up-regulation of NEK2 by microRNA-128 methylation is associated with poor prognosis in colorectal cancer.

Takahashi Y, Iwaya T, Sawada G, Kurashige J, Matsumura T, Uchi R, Ueo H, Takano Y, Eguchi H, Sudo T, Sugimachi K, Yamamoto H, Doki Y, Mori M, Mimori K.

Ann Surg Oncol. 2014 Jan;21(1):205-12. doi: 10.1245/s10434-013-3264-3. Epub 2013 Sep 18.

PMID:
24046120
15.

Frequent epigenetic silencing of PCDH10 by methylation in human colorectal cancer.

Zhong X, Zhu Y, Mao J, Zhang J, Zheng S.

J Cancer Res Clin Oncol. 2013 Mar;139(3):485-90. doi: 10.1007/s00432-012-1353-5. Epub 2012 Nov 22.

PMID:
23180019
16.

The rs6983267 SNP is associated with MYC transcription efficiency, which promotes progression and worsens prognosis of colorectal cancer.

Takatsuno Y, Mimori K, Yamamoto K, Sato T, Niida A, Inoue H, Imoto S, Kawano S, Yamaguchi R, Toh H, Iinuma H, Ishimaru S, Ishii H, Suzuki S, Tokudome S, Watanabe M, Tanaka J, Kudo SE, Mochizuki H, Kusunoki M, Yamada K, Shimada Y, Moriya Y, Miyano S, Sugihara K, Mori M.

Ann Surg Oncol. 2013 Apr;20(4):1395-402. doi: 10.1245/s10434-012-2657-z. Epub 2012 Sep 14.

PMID:
22976378
17.

Regulation of microRNA-1288 in colorectal cancer: altered expression and its clinicopathological significance.

Gopalan V, Pillai S, Ebrahimi F, Salajegheh A, Lam TC, Le TK, Langsford N, Ho YH, Smith RA, Lam AK.

Mol Carcinog. 2014 Feb;53 Suppl 1:E36-44. doi: 10.1002/mc.21993. Epub 2013 Sep 5.

PMID:
24009195
18.

Expression of SATB1 promotes the growth and metastasis of colorectal cancer.

Zhang Y, Tian X, Ji H, Guan X, Xu W, Dong B, Zhao M, Wei M, Ye C, Sun Y, Yuan X, Yang C, Hao C.

PLoS One. 2014 Jun 27;9(6):e100413. doi: 10.1371/journal.pone.0100413. eCollection 2014.

19.

Overexpression of RhoGDI2 correlates with tumor progression and poor prognosis in colorectal carcinoma.

Li X, Wang J, Zhang X, Zeng Y, Liang L, Ding Y.

Ann Surg Oncol. 2012 Jan;19(1):145-53. doi: 10.1245/s10434-011-1944-4. Epub 2011 Aug 23.

PMID:
21861235
20.

Overexpression of HOXA1 correlates with poor prognosis in patients with hepatocellular carcinoma.

Zha TZ, Hu BS, Yu HF, Tan YF, Zhang Y, Zhang K.

Tumour Biol. 2012 Dec;33(6):2125-34. doi: 10.1007/s13277-012-0472-6. Epub 2012 Aug 4.

PMID:
22864671
Items per page

Supplemental Content

Write to the Help Desk